Page last updated: 2024-10-27

fluorouracil and Medulloblastoma

fluorouracil has been researched along with Medulloblastoma in 6 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research Excerpts

ExcerptRelevanceReference
" Both dosage and releasing time can be adjusted."1.27[Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites]. ( Himuro, H; Inoue, N; Kaetsu, I; Kitamura, K; Kubo, O; Sakairi, M; Tajika, T; Tajika, Y; Tohyama, T; Yoshida, M, 1986)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morrison, LC1
McClelland, R1
Aiken, C1
Bridges, M1
Liang, L1
Wang, X1
Di Curzio, D1
Del Bigio, MR1
Taylor, MD1
Werbowetski-Ogilvie, TE1
Tsuchida, T1
Watanabe, E1
Nakayama, H1
Sasaki, A1
Nakamura, S1
Sasaki, M1
Fujiwara, T1
Nemoto, S1
Fujiwara, K1
Yanagibashi, K1
Hayakawa, I1
Nomura, K1
Kawakami, K1
Kawamoto, K1
Oka, N1
Kawamura, Y1
Matsumura, H1
Ito, T1
Ohyama, A1
Levin, VA1
Kubo, O1
Himuro, H1
Inoue, N1
Tajika, Y1
Tajika, T1
Tohyama, T1
Sakairi, M1
Yoshida, M1
Kaetsu, I1
Kitamura, K1
Broder, LE1
Rall, DP1

Reviews

2 reviews available for fluorouracil and Medulloblastoma

ArticleYear
Chemotherapy of primary brain tumors.
    Neurologic clinics, 1985, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Brain Stem; Child; Efl

1985
Chemotherapy of brain tumors.
    Progress in experimental tumor research, 1972, Volume: 17

    Topics: Adult; Antineoplastic Agents; Azaguanine; Bleomycin; Brain Neoplasms; Child; Cyclophosphamide; Drug

1972

Other Studies

4 other studies available for fluorouracil and Medulloblastoma

ArticleYear
Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.
    Neoplasia (New York, N.Y.), 2013, Volume: 15, Issue:4

    Topics: Adult; Animals; Antimetabolites, Antineoplastic; CD24 Antigen; Cell Line, Tumor; Cell Movement; Cell

2013
[FAR therapy in brain tumors--FT207-vitamin A-Radiation therapy (author's transl)].
    Neurologia medico-chirurgica, 1980, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Drug Therapy, Combination;

1980
[Flow cytometric studies of brain tumors--5: New sensitivity test of antineoplastic agents for brain tumors and its clinical application].
    No shinkei geka. Neurological surgery, 1986, Volume: 14, Issue:5

    Topics: Animals; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Cell Cycle; Cell Survival; Colony-Formin

1986
[Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites].
    No shinkei geka. Neurological surgery, 1986, Volume: 14, Issue:10

    Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Implants; Dysge

1986